Adamis pharmaceuticals announces a publication with the human immune monitoring center at stanford demonstrating tempol significantly inhibited multiple cytokines from covid-19 patient's cells

Tempol: a potential home treatment for covid-19 ( https://covid19.nih.gov/news-and-stories/tempol-potential-home-treatment-covid-19 ). trial to begin shortly.
ADMP Ratings Summary
ADMP Quant Ranking